A better understanding of the islets of Langerhans could lead to a new area of diabetes treatment, according to Barak Blum, PhD, one of three researchers who will provide an update on islet research during a Saturday afternoon symposium at the Virtual 80th Scientific Sessions.

Soon, many more individuals with monogenic diabetes will be properly recognized, diagnosed, and treated thanks to genetic research being conducted to improve personalized medicine for diabetes patients, according to Toni I. Pollin, MS, PhD, CGC. That research, along with other important genetic studies, will be discussed during a Saturday afternoon symposium.

Session Chair Matthew Hirschey, PhD, interviews Juleen R. Zierath, PhD, one of the speakers planned for the symposium Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14. Dr. Zierath’s presentation, “Molecular Benefits of Exercise in Countering Metabolic Stress,” begins at 8:40 a.m. CT.

Nilka Ríos Burrows, MT, MPH, and a panel of experts will discuss the intersection of diabetes and kidney disease during a two-hour virtual presentation today. “Ultimately, preventing type 2 diabetes will help prevent kidney disease and kidney failure,” Burrows said.

Smartphones. Smart watches. Fitness trackers. A panel of experts, including Ashutosh Sabharwal, PhD, Dessi Zaharieva, PhD, and David Kerr, MD, will discuss how clinicians can leverage the data collected by these devices to improve diabetes patient outcomes during a Friday afternoon virtual presentation.

On the opening day of the Scientific Sessions, a panel of experts will discuss various clinical tools for managing the diabetic foot and preventing foot ulceration—a condition one-third of diabetes patients develop during their lifetimes. The gravity of the problem is underscored by the fact that the five-year mortality rate for patients with diabetic foot…

Researchers will review new data from four clinical trials examining the latest generation of automated insulin delivery systems during a two-hour presentation on the first day of the Scientific Sessions. Richard M. Bergenstal, MD, previews the session, which will highlight the rapid evolution of the field since 2016 when the first automated insulin delivery system…

The latest clinical outcomes from the largest and longest follow-up to the Diabetes Prevention Program study will be presented during the Virtual 80th Scientific Sessions. The current phase of the Diabetes Prevention Program Outcomes Study (DPPOS) is scheduled to run through 2021 and is examining the long-term effects of metformin on cardiovascular disease and cancer…

Five experts will review critical lessons from two decades of surveillance and observational research into youth-onset diabetes during a two-hour virtual symposium at the Scientific Sessions. The expert presenters, including symposium chair Dana Dabelea, MD, PhD, are key participants in the SEARCH for Diabetes in Youth Study, a national multi-center study with centers in California,…

“Diabetes-dedicated professionals can be very successful at managing diabetes, but they want to be equally successful in reducing the risks of heart failure hospitalizations, myocardial infarctions, stroke, and cardiovascular death. They want to be equally successful in reducing the progression of kidney disease and reducing the chances of patients ending up on dialysis, or at…